A detailed history of Farther Finance Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 41,572 shares of BMY stock, worth $2.4 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
41,572
Previous 37,136 11.95%
Holding current value
$2.4 Million
Previous $1.53 Billion 40.24%
% of portfolio
0.08%
Previous 0.07%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$39.66 - $51.75 $175,931 - $229,563
4,436 Added 11.95%
41,572 $2.15 Billion
Q2 2024

Jul 31, 2024

BUY
$40.25 - $52.99 $31,073 - $40,908
772 Added 2.12%
37,136 $1.53 Billion
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $801,793 - $909,078
16,711 Added 85.03%
36,364 $1.93 Billion
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $204,488 - $244,011
4,218 Added 16.35%
30,018 $1.54 Billion
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $355,849 - $397,895
6,147 Added 31.28%
25,800 $1.5 Billion
Q2 2023

May 13, 2024

BUY
$63.71 - $70.74 $957,943 - $1.06 Million
15,036 Added 325.67%
19,653 $1.26 Billion
Q2 2023

Sep 12, 2023

BUY
$63.71 - $70.74 $957,943 - $1.06 Million
15,036 Added 325.67%
19,653 $1.26 Billion
Q1 2023

May 13, 2024

SELL
$65.71 - $74.53 $1.67 Million - $1.89 Million
-25,401 Reduced 84.62%
4,617 $320 Million
Q1 2023

Sep 12, 2023

BUY
$65.71 - $74.53 $187,864 - $213,081
2,859 Added 162.63%
4,617 $320 Million
Q4 2022

Sep 11, 2023

BUY
$68.48 - $81.09 $120,387 - $142,556
1,758 New
1,758 $126 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.